Microbiome and anticancer immunosurveillance
- Autores: Laurence Zitvogel, Maha Ayyoub, Bertrand Routy, Guido Kroemer
- Localización: Cell, ISSN 0092-8674, Vol. 165, Nº. 2, 2016, págs. 276-287
- Idioma: inglés
- Enlaces
-
Resumen
Anticancer immune responses can be considered a desirable form of autoimmunity that may be profoundly shaped by the microbiome. Here, we discuss evidence for the microbiome’s influence on anti-tumor immunosurveillance, including those that are indirect and can act at a distance, and we put forward hypotheses regarding mechanisms of how these effects are implemented. These may involve cross-reactivity between microbial and tumor antigens shaping T cell repertoires and/or microbial products stimulating pattern recognition receptors that influence the type and intensity of immune responses. Understanding how the microbiome impacts natural cancer immunosurveillance as well as treatment-induced immune responses will pave the way for more effective therapies and prophylactics.
